AU2001286009A1 - Method for massive directed mutagenesis - Google Patents

Method for massive directed mutagenesis

Info

Publication number
AU2001286009A1
AU2001286009A1 AU2001286009A AU8600901A AU2001286009A1 AU 2001286009 A1 AU2001286009 A1 AU 2001286009A1 AU 2001286009 A AU2001286009 A AU 2001286009A AU 8600901 A AU8600901 A AU 8600901A AU 2001286009 A1 AU2001286009 A1 AU 2001286009A1
Authority
AU
Australia
Prior art keywords
massive
directed mutagenesis
mutagenesis
concerns
directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286009A
Inventor
Stephane Blesa
Marc Delcourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomethodes SA
Original Assignee
Biomethodes SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomethodes SA filed Critical Biomethodes SA
Publication of AU2001286009A1 publication Critical patent/AU2001286009A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1031—Mutagenizing nucleic acids mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Ecology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Gyroscopes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

The invention concerns the field of molecular biology and more particularly that of mutagenesis. It concerns a method of high-rate directed mutagenesis, that is the formation of numerous directed mutants in reduced time and with reduced number of steps. Said method is therefore referred to as massive mutagenesis.
AU2001286009A 2000-08-25 2001-08-24 Method for massive directed mutagenesis Abandoned AU2001286009A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0010962A FR2813314B1 (en) 2000-08-25 2000-08-25 MASSIVE DIRECTED MUTAGENESIS PROCESS
FR0010962 2000-08-25
PCT/FR2001/002666 WO2002016606A2 (en) 2000-08-25 2001-08-24 Method for massive directed mutagenesis

Publications (1)

Publication Number Publication Date
AU2001286009A1 true AU2001286009A1 (en) 2002-03-04

Family

ID=8853747

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286009A Abandoned AU2001286009A1 (en) 2000-08-25 2001-08-24 Method for massive directed mutagenesis

Country Status (11)

Country Link
US (1) US7202086B2 (en)
EP (1) EP1311670B1 (en)
JP (1) JP5068917B2 (en)
AT (1) ATE354653T1 (en)
AU (1) AU2001286009A1 (en)
CA (1) CA2420721C (en)
DE (1) DE60126786T2 (en)
DK (1) DK1311670T3 (en)
ES (1) ES2282285T3 (en)
FR (1) FR2813314B1 (en)
WO (1) WO2002016606A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US6958213B2 (en) 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
US7838219B2 (en) * 2001-02-02 2010-11-23 Novici Biotech Llc Method of increasing complementarity in a heteroduplex
US20050153283A1 (en) * 2002-08-08 2005-07-14 Padgett Hal S. Method of increasing complementarity in a heteroduplex
US20040142433A1 (en) * 2001-02-02 2004-07-22 Padgett Hal S. Polynucleotide sequence variants
EP1358322B1 (en) * 2001-02-02 2009-10-28 Large Scale Biology Corporation A method of increasing complementarity in a heteroduplex polynucleotide
US7582423B2 (en) 2001-02-02 2009-09-01 Novici Biotech Llc Population of polynucleotide sequence variants
FR2823219B1 (en) * 2001-04-10 2003-07-04 Pasteur Institut MUTANTS OF DESOXYCYTIDINE KINASE WITH ENLARGED ENZYMATIC ACTIVITY
US7647184B2 (en) 2001-08-27 2010-01-12 Hanall Pharmaceuticals, Co. Ltd High throughput directed evolution by rational mutagenesis
US7078211B2 (en) 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
DE60332358D1 (en) 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd PROTEASE-RESISTANT MODIFIED INTERFERON ALPHA POLYPEPTIDE
EP1544296B8 (en) * 2003-12-18 2009-08-05 Biomethodes Method for massive directed mutagenesis
FR2883885B1 (en) * 2005-04-05 2010-12-10 Biomethodes RECOMBINATION IN VITRO CIRCULAR
FR2886943B1 (en) 2005-06-10 2007-09-07 Biomethodes Sa METHOD OF SELECTING STABLE PROTEINS UNDER STANDARD PHYSICO-CHEMICAL CONDITIONS
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
FR2897068B1 (en) * 2006-02-03 2008-04-18 Biomethodes Sa IMPROVED KANAMYCINE KINASE II AND USES THEREOF
US20100260704A1 (en) * 2006-03-08 2010-10-14 Biomethodes Human interferon-gamma (infgamma) variants
MX353478B (en) * 2007-07-31 2018-01-15 Bp Corp North America Inc Star Tailored multi-site combinatorial assembly.
EP3514175A1 (en) 2012-12-17 2019-07-24 Laboratoire Français du Fractionnement et des Biotechnologies Use of monoclonal antibodies for the treatment of inflammation and bacterial infections
WO2015011285A2 (en) 2013-07-26 2015-01-29 Biomethodes Novel variant trichoderma reesei endoglucanases
WO2019126211A1 (en) * 2017-12-20 2019-06-27 Basf Se Gene site saturation mutagenesis (gssm) method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960707A (en) * 1987-08-17 1990-10-02 Associated Universities, Inc. Recombinant plasmids for encoding restriction enzymes DpnI and DpnII of streptococcus pneumontae
ES2078518T3 (en) * 1990-04-05 1995-12-16 Roberto Crea COMPLETE DISPLACEMENT MUTAGENESIS.
WO1993020096A1 (en) * 1991-05-08 1993-10-14 Stratagene Oligonucleotide libraries useful for producing primers
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5830696A (en) * 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
DE69934088T2 (en) * 1998-01-09 2007-06-21 University Of Utah Research Foundation, Salt Lake City METHOD FOR THE IN VITRO AMPLIFICATION OF CIRCULAR DNA
US6368861B1 (en) * 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination

Also Published As

Publication number Publication date
DE60126786D1 (en) 2007-04-05
FR2813314B1 (en) 2004-05-07
FR2813314A1 (en) 2002-03-01
JP5068917B2 (en) 2012-11-07
WO2002016606A2 (en) 2002-02-28
JP2004507243A (en) 2004-03-11
DE60126786T2 (en) 2007-11-08
WO2002016606A3 (en) 2002-06-27
ATE354653T1 (en) 2007-03-15
EP1311670A2 (en) 2003-05-21
US7202086B2 (en) 2007-04-10
ES2282285T3 (en) 2007-10-16
US20040048268A1 (en) 2004-03-11
DK1311670T3 (en) 2007-06-18
CA2420721C (en) 2013-11-12
EP1311670B1 (en) 2007-02-21
CA2420721A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001286009A1 (en) Method for massive directed mutagenesis
AU2002309510A1 (en) Method for modifying plant biomass
AU2003299585A1 (en) Water-soluble products and methods of making and using the same
EP0913466A3 (en) Method for producing L-leucine
EP1424398A3 (en) Method for producing L-glutamine by fermentation and L-glutamine producing bacterium
AU2001266072A1 (en) Flat gasket and method for the production thereof
AU2003251897A1 (en) Hidden band brasserie, blank and methods of making same
WO2002018587A1 (en) Process for producing biopterins
AU7406194A (en) (in situ) extraction of microbial dna
AU2002336930A1 (en) Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture
AU2001275659A1 (en) Extracts from sophora species, method for producing the same and their use
AU2001290322A1 (en) Fuel cell and production method therefor
AU2001292318A1 (en) Fuel cell and production method therefor
WO2004050673A3 (en) Methods for synthesizing polysaccharides
AU2003240700A1 (en) Security element and method for production thereof
AU2001283132A1 (en) Enhancement of industrial production by increasing substrate transport
EP1591520A3 (en) Microorganism producing L-threonine having inactivated tyR gene, method of producing the same and method of producing L-threonine using the microorganism
AU2002226308A1 (en) Method for producing dnda
AU2003247599A1 (en) Methods of modulating cytokinin related processes in a plant using b3 domain proteins
AU2001256737A1 (en) Complex culture, process for producing complex culture, pre-culture, process forproducing pre-culture and process for producing microbial preparations
WO2004006855A3 (en) Rhodococcus equi mutants and vaccines comprising same
AU2003278226A1 (en) Method for producing acrylic acid from propane, in the absence of molecular oxygen
AU2001254864A1 (en) Cell culture method, cell cluster obtained by said methods and use thereof
WO2003000875A3 (en) Vitamin b6-phosphate phosphatase
AU2001277606A1 (en) Method for extracting and improving digestibility of palmaria palmata proteins